Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.

AusPAR: Brimonidine (as tartrate)

Australian Public Assessment Report

AusPAR

AusPAR: Brimonidine (as tartrate) [PDF, 697.42 KB]

AusPAR: Brimonidine (as tartrate) [Word, 617.77 KB]

Attachment: Product information: Brimonidine (as tartrate) [PDF, 207.27 KB]

Attachment: Product information: Brimonidine (as tartrate) [Word, 91.38 KB]

Attachment: Extract from the Clinical Evaluation Report: Brimonidine (as tartrate) [PDF, 2.58 MB]

Attachment: Extract from the Clinical Evaluation Report: Brimonidine (as tartrate) [Word, 3.24 MB]

Device/Product Name

Mirvaso

Active ingredients

Brimonidine (as tartrate)

AusPAR Date

23 January 2015

Published

5 March 2015

Submission Number

PM-2013-01459-1-5

Submission Type

New indication, New dosage form, New formulation, New strength

Decision

Approved